Bayer AG (OTC:BAYRY) – Stock analysts at Jefferies Group issued their Q3 2016 earnings per share estimates for Bayer AG in a research note issued on Thursday. Jefferies Group analyst J. Holford expects that the firm will post earnings of $1.78 per share for the quarter. Jefferies Group also issued estimates for Bayer AG’s FY2017 earnings at $8.83 EPS.

Earnings History and Estimates for Bayer AG (OTC:BAYRY)

Separately, Citigroup Inc. raised shares of Bayer AG from a “neutral” rating to a “buy” rating in a report on Thursday, August 25th.

Shares of Bayer AG (OTC:BAYRY) opened at 98.64 on Monday. The company’s 50-day moving average is $102.76 and its 200-day moving average is $106.05. The company has a market capitalization of $81.57 billion, a price-to-earnings ratio of 16.26 and a beta of 1.35. Bayer AG has a 12-month low of $94.36 and a 12-month high of $135.71.

Bayer AG Company Profile

Bayer AG is a Germany-based chemical and pharmaceutical company. The Company’s business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals.

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.